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The endocannabinoid system, which comprises endog-
enous ligands and various receptors, plays an important
role in immune control. Endocannabinoid signalling
impacts crucial immune cell functions such as migration
and chemotaxis and acts as an auto-protective and com-
pensatory system under inflammatory conditions. The
inflammatory mediator Matrix-metalloproteinase 9
(MMP-9) helps immune cells to migrate to the sites of
inflammation by degrading the extracellular matrix.
The aim of our study was to determine the effect of can-
nabinoid signalling on the secretion of MMP-9 by macro-
phages. U937 monocytes were differentiation to
macrophages by incubation with PMA (100 nM) for 48 h,
and primary human macrophages were isolated from
whole blood. Treatment with the synthetic cannabinoid
WIN 55, 212-2 (2 or 4 uM) induced a dose dependent
inhibition of MMP-9 secretion as shown by activity assay
and western blot analysis of conditioned media. Kinetic
analysis of cell lysates by western blot showed intracellu-
lar accumulation of MMP-9 going along with the inhib-
ited secretion, proposing inhibition of the secretion
process as a mechanism. Quantitative real-time-PCR was
used to measure MMP-9 mRNA and revealed a possible
negative feedback loop on the transcriptional level which
involves MAP-kinases as shown by phospho-specific west-
ern blot analysis. The effect could not be blocked by phar-
macological inhibition of the known cannabinoid
receptors CB1, CB2, and TRPV1, but was stereospecific, as
it could not be reproduced with the enantiomer WIN55,
212-3. The effect therefore seems to be mediated by a yet
unidentified cannabinoid-binding site.
Our results suggest that cannabinoid-induced inhibition
of MMP-9 secretion presents a new mechanism of anti-
inflammatory action of the cannabinoid system and helps
to provide a basis for the development of cannabinoid-
based drugs for inflammatory diseases.
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